A new name, an old crisis: Metabolic dysfunction at the core of polyendocrine metabolic ovarian syndrome.
Where this comes from
- Record sourced from PubMed, PMID 42710488.
- Also identified by DOI 10.1016/j.cmet.2026.07.018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Affecting hundreds of millions of women worldwide, polyendocrine metabolic ovarian syndrome (PMOS, formerly polycystic ovary syndrome) carries a significantly higher risk of cardiovascular and metabolic diseases. Here we discuss how renaming this disease reframes a profoundly misunderstood condition for which basic metabolic research remains critically underfunded and fragmented.